Cabrera Silva, María Del Carmen | Hematología y Hemoterapia

Resultados: 37
Tipo Título / Nombre Autor(es) Año
Depth of response as surrogate marker for progression-free survival and overall survival in elderly newly diagnosed myeloma patients treated with VMP and RD: GEM2010MAS65 Mateos MV, Martínez-López J, Hernández M, Martínez R, Rosiñol L, Ocio EM, Pérez de Oteyza J, Oriol A, Bargay J, Gironella M, &10, Martín J, Cabrera C, Rubia J de la, Puig N, Paiva B, Cedeña MT, Rodríguez-Otero P, Bladé J, Lahuerta JJ, San Miguel J 2017
NCCN-IPI in Patients with Diffuse Large B CELL Lymphoma Treated with DA-R-EPOCH. Retrospective Analysis Bergua Burgues JM, López-Gómez L, Ibañez F, Suarez-Varela S, Prieto-Fernández J, Carnicero F, Casas I, Martín-Mateos ML, Cabrera C, Arcos-Carmona MJ, Bañas MH, Bermejo N, Sanz MA, Bobillo-Varela S, López A 2016
Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM Mateos MV, Martínez-López J, Hernández MT, Ocio EM, Rosiñol L, Martínez R, Teruel AI, Gutiérrez NC, Martín Ramos ML, Oriol A, Bargay J, Bengoechea E, González Y, Pérez de Oteyza J, Gironella M, Encinas C, Martín J, Cabrera C, Paiva B, Cedena MT, Puig N, B 2016
Minimal residual disease monitoring and immune profiling using second generation flow cytometry in elderly multiple myeloma Paiva B, Cedena MT, Puig N, Arana P, Vidriales MB, Cordon L, Flores-Montero J, Gutierrez NC, Martín-Ramos ML, Martinez-Lopez J, Ocio EM, Hernandez MT, Teruel AI, Rosiñol L, Echeveste MA, Martinez R, Gironella M, Oriol A, Cabrera C, Martin J, Bargay J, Encinas C, Gonzalez Y, Van Dongen JJ, Orfao A, Bladé J, Mateos MV, Lahuerta JJ, San Miguel JF, Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas (GEM/PETHEMA) Cooperative Study 2016
Relationship between Antiphospholipid Syndrome clinical manifestations and multiple positive antiphospholipid antibodies. Sigüenza R, Bermejo N, Casas I, Ibañez F, Bañas MH, Bergua JM, Arcos MJ, Prieto J, Martin-Mateos ML, Cabrera C, Perez-Leal FA 2015
CD38 expression on CD34+ Bone Marrow Cells (BM) as a tool in low grade Myelodysplactics Syndromes (MDS) Sigüenza R, Bañas MH, Casas I, Ibañez F, Bermejo N, Bergua JM, Arcos MJ, Prieto J, Martin-Mateos ML, Cabrera C, Perez-Leal FA 2015
Dos pacientes mujeres, jóvenes, con fiebre y un mismo destino Sigüenza Salgado R, Ibáñez Espacio F, Casas Avilés I, Flores Guerrero A, Bañas Llanos H, Martín Aguilera C, Bermejo Vega N, Arcos Carmona MJ, Martín Mateos M, Prieto Fernández J, Cabrera Silva C, Carnicero F, Bergua Burgués J 2014
Relevance of parallel use of galactomanann and betaglucan assay in the diagnosis and follow up of fungal infection Bergua Burgues JM, Siguenza R, Pazos C, Fernandez-Leyva H, Ibañez F, Prieto J, Martín Mateos ML, Casas I, Bañas H, Cabrera C, Carnicero F, Bermejo-Vega N 2014
Flow cytometric CD38 expression on CD34+ cells as a simple diagnostic test in myelodysplastic syndromes (MDS) Bañas Llanos MH, Ibañez Espacio F, Martín-Aguilera C, Arcos Carmona MJ, Carnicero F, Cabrera C, Martín Mateos ML, Fernández H, Prieto J, Bermejo N, García-Blanco MJ, Bergua Burgués J 2013
Azacytidine 75 mg/m2 ×5 day in high-risk myelodisplastic syndromes and acute myeloid leukemia refractory/relapsed patients Bergua Burgués J, Arcos MJ, Carnicero F, Prieto J, Cabrera C, Martín-Mateos ML, Fernández H, Bañas H, Ibañez F, Martín-Aguilera C, Siguenza R, Bermejo N, García-Blanco MJ, Sánchez J 2013